Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1988 Mar;56(3):548–551. doi: 10.1128/iai.56.3.548-551.1988

Antibacterial activity of recombinant murine beta interferon.

T Fujiki 1, A Tanaka 1
PMCID: PMC259324  PMID: 3343048

Abstract

Recombinant murine beta interferon was protective and therapeutic for mice against Listeria monocytogenes infection in vivo. The recombinant murine beta interferon caused enhanced H2O2 release by macrophages in vivo, but not in vitro.

Full text

PDF
548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee D. K., Sharp A. K., Lowrie D. B. The effect of gamma-interferon during Mycobacterium bovis (BCG) infection in athymic and euthymic mice. Microb Pathog. 1986 Apr;1(2):221–224. doi: 10.1016/0882-4010(86)90024-0. [DOI] [PubMed] [Google Scholar]
  2. Baron S., Weigent D., Stanton G. J., Peterson J. The protective role of endogenous interferon in viral, bacterial, and protozoal infections. Antiviral Res. 1985;Suppl 1:173–183. doi: 10.1016/s0166-3542(85)80026-7. [DOI] [PubMed] [Google Scholar]
  3. Billiau A., Van Damme J., Opdenakker G., Fibbe W. E., Falkenburg J. H., Content J. Interleukin 1 as a cytokine inducer. Immunobiology. 1986 Sep;172(3-5):323–335. doi: 10.1016/S0171-2985(86)80114-0. [DOI] [PubMed] [Google Scholar]
  4. Boraschi D., Ghezzi P., Pasqualetto E., Salmona M., Nencioni L., Soldateschi D., Villa L., Tagliabue A. Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology. 1983 Nov;50(3):359–368. [PMC free article] [PubMed] [Google Scholar]
  5. Bukholm G., Berdal B. P., Haug C., Degré M. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun. 1984 Jul;45(1):62–66. doi: 10.1128/iai.45.1.62-66.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Candler R. V., Rouse B. T., Moore R. N. Regulation of interleukin 1 production by alpha and beta interferons: evidence for both direct and indirect enhancement. J Interferon Res. 1985 Winter;5(1):179–189. doi: 10.1089/jir.1985.5.179. [DOI] [PubMed] [Google Scholar]
  7. Degré M., Rollag H. On the possible role of interferon in infections with non-viral agents. Tex Rep Biol Med. 1981;41:388–394. [PubMed] [Google Scholar]
  8. Edwards C. K., 3rd, Hedegaard H. B., Zlotnik A., Gangadharam P. R., Johnston R. B., Jr, Pabst M. J. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma. J Immunol. 1986 Mar 1;136(5):1820–1827. [PubMed] [Google Scholar]
  9. Higashi Y., Sokawa Y., Watanabe Y., Kawade Y., Ohno S., Takaoka C., Taniguchi T. Structure and expression of a cloned cDNA for mouse interferon-beta. J Biol Chem. 1983 Aug 10;258(15):9522–9529. [PubMed] [Google Scholar]
  10. Kawasaki H., Moriyama M., Tanaka A. Augmentation of endotoxin fever by recombinant human beta interferon in rabbits. Infect Immun. 1987 May;55(5):1121–1125. doi: 10.1128/iai.55.5.1121-1125.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kiderlen A. F., Kaufmann S. H., Lohmann-Matthes M. L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol. 1984 Oct;14(10):964–967. doi: 10.1002/eji.1830141019. [DOI] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matsuda S., Utsumi J., Kawano G. Purification and characterization of recombinant mouse interferon-beta. J Interferon Res. 1986 Oct;6(5):519–526. doi: 10.1089/jir.1986.6.519. [DOI] [PubMed] [Google Scholar]
  15. Mitsuyama M., Takeya K., Nomoto K., Shimotori S. Three phases of phagocyte contribution to resistance against Listeria monocytogenes. J Gen Microbiol. 1978 May;106(1):165–171. doi: 10.1099/00221287-106-1-165. [DOI] [PubMed] [Google Scholar]
  16. Nakane A., Minagawa T. The significance of alpha/beta interferons and gamma interferon produced in mice infected with Listeria monocytogenes. Cell Immunol. 1984 Oct 1;88(1):29–40. doi: 10.1016/0008-8749(84)90049-2. [DOI] [PubMed] [Google Scholar]
  17. Nathan C. F., Silverstein S. C., Brukner L. H., Cohn Z. A. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med. 1979 Jan 1;149(1):100–113. doi: 10.1084/jem.149.1.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Passwell J. H., Shor R., Shoham J. The enhancing effect of interferon-beta and -gamma on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro. J Immunol. 1986 Apr 15;136(8):3062–3066. [PubMed] [Google Scholar]
  19. Rollag H., Mørland B., Degré M. Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages. Acta Pathol Microbiol Immunol Scand B. 1982 Apr;90(2):113–118. doi: 10.1111/j.1699-0463.1982.tb00091.x. [DOI] [PubMed] [Google Scholar]
  20. Tanaka T., Naruto M., Kawano G. Production of recombinant mouse beta-interferon. J Interferon Res. 1986 Aug;6(4):429–435. doi: 10.1089/jir.1986.6.429. [DOI] [PubMed] [Google Scholar]
  21. Wang E., Michl J., Pfeffer L. M., Silverstein S. C., Tamm I. Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization. J Cell Biol. 1984 Apr;98(4):1328–1341. doi: 10.1083/jcb.98.4.1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Weigent D. A., Huff T. L., Peterson J. W., Stanton G. J., Baron S. Role of interferon in streptococcal infection in the mouse. Microb Pathog. 1986 Aug;1(4):399–407. doi: 10.1016/0882-4010(86)90071-9. [DOI] [PubMed] [Google Scholar]
  23. von der Lippe E., Frøland S., Rollag H., Degre M. Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages. Acta Pathol Microbiol Immunol Scand B. 1986 Oct;94(5):343–346. doi: 10.1111/j.1699-0463.1986.tb03064.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES